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Abstract Expression of cytokine-regulated signal transduc-
er and activator of transcription (STAT) proteins was histo-
chemically assessed in patients diagnosed as having
Hashimoto's disease or focal lymphocytic thyroiditis (n0
10). All surgical specimens showed histological features of
lymphocytic thyroiditis, including a diffuse infiltration with
mononuclear cells and an incomplete loss of thyroid fol-
licles, resulting in the destruction of glandular tissue archi-
tecture. Immunohistochemical analysis demonstrated
differential expression patterns of the various members of
the STAT transcription factors examined, indicating that
each member of this conserved protein family has its distinct
functions in the development of the disease. Using an anti-
body that specifically recognized the phosphorylated tyro-
sine residue in position 701, we detected activated STAT1
dimers in numerous germinal macrophages and infiltrating
lymphocytes as well as in oncocytes. In contrast, STAT3
expression was restricted to epithelial cells and showed a
clear colocalization with the antiapoptotic protein Bcl-2.
Moreover, expression of phospho-STAT3 was associated
with low levels of stromal fibrosis, suggesting that STAT3
serves as a protective factor in the remodeling of the in-
flamed thyroid gland. Phospho-STAT5 immunoreactivity
was detected in numerous infiltrating cells of hematopoietic
origin and, additionally, in hyperplastic follicular epithelia.
This tissue distribution demonstrated that activated STAT5
molecules participate in both lymphocytopoiesis and possi-
bly also in the buildup of regenerating thyroid follicles.
Taken together, the cell-type-specific expression patterns
of STAT proteins in human lymphocytic thyroiditis reflect
their distinct and partially antagonistic roles in orchestrating
the balance between degenerating and regenerating process-
es within a changing cytokine environment.
Keywords Lymphocytic thyroiditis . Hashimoto's
disease . STAT. Stromal fibrosis
Introduction
Hashimoto's thyroiditis, one of the most prevalent chronic
autoimmune diseases affecting humans, is caused by auto-
reactive T lymphocytes that infiltrate the thyroid gland and
ultimately lead to its progressive destruction. Numerous
clinical and experimental studies have suggested a break-
down of organ-specific immune tolerance and inappropriate
immune reactions against cellular components of the thyroid
gland as the etiological basis of the disease. Accordingly,
the histological hallmark of Hashimoto's disease is a
chronic loss of the follicular organ structure and its con-
comitant replacement by lymphoid infiltrates including the
formation of germinal centers and fibrosis [1–4]. Typically,
the disease is characterized by the presence of a diffuse
thyroid goiter, although in later stages the gland may
progressively shrink until completely atrophic. Patients
with chronic autoimmune thyroiditis usually present with
elevated serum titers of autoantibodies such as antiperoxidase
and antithyroglobulin as well as increased serum concentrations
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of thyroid-stimulating hormone (TSH) which result from
peripheral hypothyroidism [4]. Although the diagnostic cri-
teria for lymphocytic thyroiditis describe a well-defined
disease entity, its pathogenesis is only poorly understood.
Particularly, the role of extracellular cytokines and their
intracellular signal pathways involved in lymphocyte re-
cruitment to sites of thyroidal inflammation are, in general,
not well defined.
Avariety of cytokines including pro- and anti-inflammatory
interleukins (IL) and interferon-γ (IFN-γ) have been detected
in surgical specimens from patients with Hashimoto's disease
and in rodents with experimental autoimmune thyroiditis
induced by immunization with thyroglobulin and
Freund's adjuvant [5–9]. Cytokines execute their pleio-
tropic effects mainly through the activation of members
of the class of signal transducer and activator of tran-
scription (STAT) proteins. Upon binding of a distinct
cytokine to its cognate membrane receptor, the receptor-
associated Janus kinases (JAKs) become autophosphory-
lated and consecutively phosphorylate critical tyrosine
residues on the cytoplasmic tails of the receptor, thereby
generating docking sites for STAT proteins or other
intracellular signaling molecules [10–12]. STAT proteins
are recruited to the phosphotyrosine-containing motifs
on the cytokine receptor tails via their Src homology 2
domain and, in turn, are phosphorylated on a signature
tyrosine within their carboxy termini. The activated
STAT molecules then enter the nucleus as tyrosine-
phosphorylated dimers where they recognize palindrom-
ic DNA sequences in the promoter region of cytokine-
driven genes to induce gene expression.
Diversity in cytokine signaling is provided by the spec-
ificity of receptor binding and the dimerization of tyrosine-
phosphorylated STAT variants. In humans, seven different
members of the evolutionary conserved protein family of
STAT transcription factors have been identified. Despite
considerable structural similarity, STAT1 and STAT3
produce opposing physiological effects: whereas STAT1
involved in interferon signaling induces antiproliferative
and apoptotic responses, IL-6-mediated STAT3 activa-
tion promotes cellular proliferation [10]. STAT5a/b pro-
teins have been identified as key signaling molecules in
normal lymphocytopoiesis as well as mammary gland
development and lactogenesis [13, 14]. However, their
expression in lymphocytic thyroiditis has not been de-
scribed so far.
This report describes the use of immunohistochemical
methods to assess the cellular distribution of STAT proteins
in thyroid tissue from patients with lymphocytic thyroiditis.
The results presented here show that STAT proteins are
differentially expressed in a cell-specific manner and that




Ten patients with lymphocytic thyroiditis, who were ad-
mitted to the University Hospital of Marburg, Germany,
for surgical therapy of diffuse swelling of the thyroid
gland, were enrolled in this study. Patients were consid-
ered eligible for this study when conventional staining of
paraffin wax-embedded thyroid tissue obtained from
(hemi)-thyroidectomy demonstrated histopathological fea-
tures of lymphocytic autoimmune thyroiditis. Thorough
clinical examination excluded other causes of thyroid
lesions such as Graves' disease, granulomatous thyroiditis
DeQuervain, or Riedel's thyroiditis. Serum samples were
collected and tested for the presence of antiperoxidase
and antithyroglobulin autoantibodies using enzyme-linked
immunoassays. All participants in the study gave their
signed informed consent to a histological examination of
thyroidal specimens. The study protocol was approved by
the local ethics committee.
Immunohistochemical Staining
After surgical resection, thyroid tissue samples were rou-
tinely fixed in 10% neutral buffered formalin and embedded
in paraffin. Serial sections of 10 μm were cut from paraffin-
embedded tissue blocks and deparaffinized through a graded
series of alcohol. Subsequently, the rehydrated sections were
heat-treated for 15 min followed by a three-step immuno-
histochemical staining procedure. For immunohistochemi-
cal detection of phospho-STAT1, we used a rabbit
polyclonal antibody, diluted 1:100 in 4% bovine serum
albumin/phosphate-buffered saline (BSA/PBS), which spe-
cifically reacted with tyrosine-phosphorylated STAT1 (Cell
Signaling). STAT1 antibody C-24 was obtained from immu-
nized rabbits (Santa Cruz) and diluted 1:500 in 4% BSA/
PBS. STAT3 and its tyrosine-phosphorylated variant were
detected using rabbit anti-STAT3 antibody H-190 and goat
anti-phospho-STAT3 antibody pSTAT3-Y705, respectively
(both from Santa Cruz). STAT5a/b immunoreactivity was
probed with rabbit polyclonal antibody N-20 (Santa Cruz).
Labeling of phospho-STAT5 was performed using the
rabbit antibody pSTAT5a/b-Y694 (Santa Cruz). Mouse
monoclonal antibodies against Bcl-2 (clone C8/144B,
M7103) and CD8 (clone 124, M0887) were both
obtained from Dako. Detection of bound immunoglobu-
lins was achieved with the ABC method employing bio-
tinylated secondary antibodies and avidin–horseradish
peroxidase complexes. Diaminobenzidine was used as a
substrate for visualization of the enzyme reaction yielding
a brown reaction product. Finally, the sections were
counterstained with Mayer's hematoxylin.
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Pathological Examination
The staining intensity for each target antigen was evaluated
using a four-point semiquantitative scoring system ranging
from 0 (indicating virtually no immunostaining) to 3 (with
the most prominent parameters). Additionally, the extent of
parenchyma replacement by collections of mononuclear
cells was graded from mild to marked. Mild infiltration
was defined as less than 10% loss of parenchyma, moderate
indicated a 10% to 50% replacement, and marked indicated
a greater than 50% replacement by cell infiltrates [1]. Ad-
ditionally, stromal fibrosis was assessed using a four-point
scale ranging from no fibrosis (0) to mild (1), moderate (2),
and severe fibrosis (3).
Statistical Analyses
Epidemiological data are presented as mean values ± stan-
dard deviations. Correlations between the different parame-
ters were calculated using Spearman's rank order correlation
coefficients. Probability values of less than 5% (p<0.05)
were considered statistically significant. All statistical anal-
yses were performed with SigmaStat Version 9.0 from
Systat Software.
Results
Characterization of the Study Cohort
All patients (n010) included in this study were clinically
characterized by the presence of goiter and showed histo-
logical features of Hashimoto's disease or focal lymphocytic
thyroiditis. Eight out of ten study participants were females;
the mean age of the study population was 39.9±12.1 years.
The majority of patients were euthyroid (nine out of ten
patients). In three patients, suppressed thyrotropin concen-
trations below the normal cutoff were detected and, inter-
estingly, we found that a pathological decrease in serum
TSH levels was significantly associated with a lack of
STAT3 expression in thyroid biopsies (p00.048). Two indi-
viduals had normal serum concentrations of free triiodothy-
ronine (fT3) and thyroxine (fT4) but a reduced level of TSH.
One patient had fT3 and fT4 levels within the normal range
and a TSH level above the normal cutoff. Elevated serum
levels of antithyroid microsomal antibodies were detected in
four patients (up to 9,460 U/ml, normal range <35 U/ml),
and three of them also had an elevated titer of antithyroglo-
bulin autoantibodies (up to 720 U/ml, normal range <40). In
two antibody-negative patients, histological examination
demonstrated, in addition to typical lymphoplasmacytic in-
filtration, either a well-differentiated, minimally invasive
follicular thyroid carcinoma (case 2) or a follicular adenoma
surrounded by fibrotic material (case 3). The characteristics
of the study population including the results from laboratory
measurements are presented in Table 1.
Histological Examination of Thyroid Samples
In immunohistochemical specimens from normal thyroid
tissue used as controls, colloid-containing follicles were
evenly distributed in a fine interstitial stroma free of infil-
trating CD8-positive cells (Fig. 1a). The prosurvival protein
Bcl-2 was rarely detectable in normal glandular tissue
(Fig. 1b). Furthermore, in controls without mononuclear
infiltration, there was no immunoreactivity above the detec-
tion threshold for the following three STAT proteins tested:
STAT1, STAT3, and STAT5 (Fig. 1c, e, g). Consequently,
we did not detect tyrosine-phosphorylated forms thereof in
normal tissue (Fig. 1d, f, h).
Tissue specimens from all study participants showed the
presence of diffuse infiltrates of mononuclear cells localized
between thyroid follicles; some of these cells stained posi-
tively for CD8 (Fig. 2a) or Bcl-2 (Fig. 2b), thus confirming
the initial clinical diagnosis of Hashimoto's disease or lym-
phocytic thyroiditis [15, 16]. Morphological alterations in
the follicular epithelium ranged from minimal irregularities
in the shape of thyrocytes and degree of papillary folding,
mainly observed in regions with mild infiltration, to a mas-
sive tissue remodeling characterized by pronounced atrophy
of the follicular epithelium. The degree of follicular destruc-
tion varied according to the extent of lymphocytic infiltra-
tion, ranging from patchy to near complete effacement of the
glandular architecture. In cases of severe interfollicular in-
filtration, thyrocytes in the vicinity of lymphoid infiltrates
often displayed a swollen, oxyphilic, and granular cyto-
plasm. Generally, epithelial oxyphilia was associated with
a significant decrease in thyroid parenchyma due to stromal
fibrosis, which was accompanied by a nearly total depletion
of colloid material in the remaining follicular lumen. The
extent of parenchyma loss was less pronounced in tissue
samples showing predominant hyperplastic changes in the
follicular epithelium. Details on the histopathological fea-
tures of biopsies from participants in the study are summa-
rized in Table 1.
In cases of chronic inflammation, follicular cells exhibited
a more or less cuboid or even slightly columnar morphology,
while mononuclear cell infiltration and stromal fibrosis were
relatively mild. Lymphoid follicles with activated germinal
centers were present in all samples and were surrounded by
damaged tissue showing follicular atrophy, colloid microfol-
licles, and occasionally, intrafollicular macrophages. The ma-
jority of immune-competent cells in the germinal center
lacked expression of CD8 (less than 1% CD8-positive cells),
whereas up to one-third of infiltrating cells scattered through-
out the inflamed tissue stained positively for this marker
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Table 1 Clinical characterization of 10 patients with chronic lymphocytic thyroiditis including assessment of histopathological features
Number Age Sex Serum levels Infil Fibr CD8 Bcl2 S1 pS1 S3 pS3 S5 pS5


















































Histopathological assessment of stromal fibrosis, infiltration, and antibody staining was determined on a four-point scale ranging from 0 to 3 (00
no, 10mild, 20moderate, and 30severe). Normal ranges for the indicated laboratory values are as follows: fT3 3.1–6.5 pmol/l, fT4 7.5–21 pmol/l,
Tg-Ab <40 U/ml, TPO-Ab <35 U/ml, and TSH 0.34–5.6 mU/l.
Bcl2 Bcl-2 expression, Fibr degree of stromal fibrosis, Infil degree of infiltration, fT3 serum concentration of free triiodothyronine, fT4 serum
concentration of free thyroxine, n.d. not determined, pS1 phospho-STAT1, pS3 phospho-STAT3, pS5 phospho-STAT5, S1 STAT1, S3 STAT3, S5
STAT5, Tg-Ab serum titers of antibodies against thyroglobulin, TPO-Ab serum titers of antibodies against thyroid peroxidase, TSH thyroid-
stimulating hormone
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(≤34% CD8-positive cells). In three patients, chromogranin A
staining revealed rare calcitonin cells, which were arranged in
small groups or single cells in the parafollicular interstitium
(Fig. 2c).
STAT1 Expression in Lymphocytic Thyroiditis
Using similar staining protocols and the same set of anti-
STAT antibodies as described, we observed a cell-type-
specific and disease-associated expression of STAT proteins
in samples from patients clinically diagnosed as suffering
from lymphocytic thyroiditis. Most prominent was a posi-
tive immunostaining for STAT1 transcription factor in the
epithelial lining of structurally altered thyroid follicles, as
was visualized in all surgical specimens tested (Fig. 2d).
Atrophic follicles containing sparse colloid within a small
and irregular lumen frequently showed a positive staining
pattern with anti-STAT1 antibody, particularly when embed-
ded in a dense lymphoplasmacytic infiltrate. At higher mag-
nification, STAT1-expressing thyrocytes usually showed
characteristic features of an oxyphilic change such as a
voluminous, granular cytoplasm and enlarged, centrally, or
eccentrically located nuclei with prominent macronucleoli.
Occasionally, hyperplastic epithelium also showed a diffuse
staining pattern with STAT1-reacting antibodies, indicating
that STAT1 expression was not restricted to follicular cells
Fig. 1 Immunohistochemical
analysis fails to mark detectable
amounts of CD8 (a), Bcl-2 (b),
or the signal transducer and ac-
tivator of transcription (STAT)
proteins STAT1 (c), STAT3 (e),
and STAT5 (g) including their
corresponding tyrosine-
phosphorylated protein modifi-
cations (d, f, h) in noninflamed
thyroid tissue
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within an oxyphilic-changed epithelium. Interestingly,
STAT1 immunoreactivity in thyrocytes was higher in the
nucleus as compared to the cytosolic compartment, indicat-
ing that activated STAT1 molecules were retained in the
pleomorphic nuclei of oncocytic follicular cells. This nuclear
accumulation of STAT1 in epithelial cells was confirmed with
a polyclonal anti-STAT1 antibody, which specifically recog-
nized tyrosine-phosphorylated STAT1 dimers (Fig. 2e).
In addition to the epithelial lining of thyroid follicles,
there was a strong expression of STAT1 in single cells
scattered throughout areas of diffuse lymphoplasmacytic
infiltration. These anti-STAT1-immunoreactive cells dis-
played a small rim of cytoplasm around their nuclei, sug-
gesting that they were immune-competent cells of
hematopoietic origin. Although readily detectable in the
marginal zone surrounding activated lymphoid follicles,
the density of these STAT1-expressing cells per microscopic
field was not high as compared to cells expressing STAT5
(see Fig. 3c). Furthermore, numerous macrophages in the
inner germinal center stained positively for STAT1, some of
them exhibited engulfed phagocytic material within their
prominent cytoplasm (Fig. 2f). Occasionally, phospho-
STAT1-positive macrophages were also detected in the
interior of thyroid follicles where they had lost contact to
the epithelium (data not shown).
Expression of STAT3 and Antiapoptotic Bcl-2
In five out of ten patients with chronic lymphocytic thyroid-
itis, we found intrathyroidal expression of STAT3, which was
predominately located in regions with almost complete de-
struction of the follicular architecture. While STAT1 was
expressed both in epithelial cells as well as infiltrating mono-
nuclear cells, the cellular distribution of STAT3 was restricted
to altered thyrocytes in residual follicles with oxyphilia
(Fig. 3a). Also, in contrast to STAT1, we failed to observe
nuclear accumulation of STAT3, even when using an antibody
specifically recognizing tyrosine-phosphorylated STAT3
(Fig. 3b). Importantly, we found that activation of STAT3
was significantly associated with a lower degree of stromal
fibrosis in the inflamed thyroid gland (p00.0015).
Since STAT3 and STAT5 are both known to be potent
transcriptional activators of the bcl2 gene, we next investi-
gated the tissue distribution of this antiapoptotic protein. As
expected, Bcl-2 immunoreactivity was observed in interfol-
licular mononuclear cells as well as in lymphoid follicles
Fig. 2 Expression of CD8 (a),
Bcl-2 (b), chromogranin A (c),
STAT1 (d, f), and tyrosine-
phosphorylated STAT1 (e) in
surgical samples from patients
with lymphocytic thyroiditis as
assessed by means of immuno-
histochemical staining using
specific antibodies. The nuclear
accumulation of phospho-
STAT1 in epithelial cells lining
thyroid follicles (e) and STAT1
localization in macrophages
scattered throughout the center
of a germinal lymph node (f) is
shown
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where the expression of Bcl-2 was predominantly restricted
to B cells in the mantle zone and, to a lesser extent, to
lymphocytes inside reactive germinal centers (Fig. 2b). In
addition, we detected a significant Bcl-2 staining in thyroid
follicles lined with oxyphilic epithelia, although the staining
intensity in oncocytes was usually below that in the
lymphocytes.
Distribution of STAT5 and its Tyrosine-Phosphorylated
Variant
STAT5a/b was preferentially expressed in specimens show-
ing modest lymphocytic infiltration in areas with regenerat-
ing thyroidal colloids of reduced size (Fig. 3c). Nuclear
accumulation was a hallmark of STAT5 distribution.
Tyrosine-phosphorylated STAT5 molecules were also pres-
ent in the cytosol, albeit in a lower concentration, as judged
from the more intense nuclear staining (Fig. 3d). Similar to
STAT1, anti-STAT5 antibodies reacted with both infiltrating
mononuclear cells as well as follicular cells. However,
we found neither statistically significant correlations be-
tween STAT1 and STAT5 expression nor between the
phosphorylated STAT dimers thereof. Phospho-STAT5
expression was detected less frequently than STAT1, as
only 70% of cases showed a clear STAT5 immunoreac-
tivity. Epithelial STAT5 expression was most prominent
in a follicular adenoma, which was diagnosed as an
incidental finding (case 3). Serial sections revealed that
Bcl-2, phospho-STAT3 and STAT5 were often coex-
pressed in the epithelial lining from the same thyroid
follicles (Fig. 4). However, colocalization was not oblig-
atory as Bcl-2-positive follicular structures frequently
showed no staining with STAT5 antibodies.
Discussion
In this study, we examined the expression of different STAT
proteins in surgical samples from patients with lymphocytic
thyroiditis, a disease characterized by diffuse infiltration of
the thyroid gland with CD4+ and CD8+ T cells and plasmo-
cytes. Our immunohistochemical data demonstrated that
STAT1 transcription factor is abundantly expressed in the
nuclei of oncocytes, also known as Hürthle cells, Askanazy
cells, or oxyphilic cells, which are a hallmark of Hashimo-
to's disease, but not exclusively confined to this entity.
There was evidence of a high level of tyrosine phosphory-
lation of STAT1 in these cells, as judged from staining with
a phosphospecific STAT1 antibody which specifically
reacted with the critical tyrosine residue in position 701
required for phosphodimer formation. Nuclear accumulation
of STAT1 in the follicular epithelium was most prominent in
areas displaying extensive disruption of the thyroid archi-
tecture due to the presence of a chronic inflammatory mi-
lieu. Tyrosine-phosphorylated STAT1 was also detected in
macrophages located in intrathyroidal germinal centers, which
displayed characteristic features of antigen-presenting cells
such as phagocytosis of cell debris and an overall amoeboid
morphology. The presence of phosphorylated STAT1 mole-
cules in follicular macrophages is considered to be a marker
for cell activation, pointing to the putative role of phospho-
STAT1 as a disease-promoting factor in the orchestration of
primary immune responses against thyroidal tissue.
Previous studies have shown that IFN-γ, a prototypic
Th1 cytokine and potent activator of STAT1 tyrosine phos-
phorylation, stimulates macrophages and dendritic cells to
induce MHC class II expression [17]. Interestingly, trans-
genic mice constitutively overexpressing IFN-γ specifically
Fig. 3 Detection of STAT3 (a),
phospho-STAT3 (b), STAT5
(c), and phospho-STAT5 (d) in
specimens from patients with
lymphocytic thyroiditis as
demonstrated by histopatholog-
ical examination using appro-
priate primary antibodies
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in thyroid follicle cells have been reported to develop pri-
mary hypothyroidism and growth retardation resulting from
chronic, cytokine-mediated inflammation [8, 18]. Kimura et
al. reported that in this transgenic mice line, thyroidal se-
cretion of IFN-γ was associated with a transformation of
normal thyrocytes into oncocytes [19]. When transgenic
mice expressing IFN-γ in thyrocytes were crossed with
RAG-2 knockout animals, which failed to generate mature
T and B lymphocytes because of an inability to initiate the V
(D)J recombination process, the architecture of the thyroid
gland still remained disturbed despite the absence of infil-
trating lymphocytes [18]. This observation suggests that
local IFN-γ production in the thyroid gland per se causes
the chronic hypothyroid phenotype independent of the cel-
lular source of the cytokine [19–21].
When backcrossed in a NOD.H-2h4 background, the mice
overexpressing IFN-γ in the thyrocytes failed to develop
spontaneous thyroiditis, but instead showed a milder thyroidal
inflammation and decreased frequency of activated CD44+
lymphocytes in cervical lymph nodes upon immunization
with murine thyroglobulin and Freund's adjuvant [22]. Due
to conflicting results, the significance of IFN-γ in the patho-
genesis of experimental autoimmune thyroiditis still remains
controversial [23, 24]. Additionally, one should be cautious in
drawing conclusions from these animal studies as far as the
phenotype of the human disease is concerned because in the
transgenic mouse models, IFN-γ is produced ectopically by
thyrocytes and not physiologically by infiltrating lympho-
cytes, which under usual circumstances, direct the dysregu-
lated immune reactions against follicular autoantigens [18].
Our finding of high expression levels of phospho-STAT1 in
the nuclei of oncocytes underlines the hypothesis that inter-
ferons most likely modulate the uniform morphological alter-
ations in these cells via the induction of STAT1 tyrosine
phosphorylation.
In contrast to the considerable expression of STAT1 inmost
of the samples examined, STAT3 was detected in only half of
the study participants (five out of ten patients). Generally,
expression of STAT3 and phospho-STAT3 was low and con-
fined to restricted groups of adjacent thyroid follicles. Staining
of consecutive tissue slides clearly demonstrated colocaliza-
tion of either STAT3 or STAT5 with Bcl-2, confirming previ-
ous results that bcl2 is a target gene of STAT3 and STAT5
transcription factors important for preventing apoptotic cell
death [15, 25–27]. Whereas STAT3-expressing epithelia usu-
ally displayed Bcl-2 immunoreactivity, there were abundant
follicles with Bcl-2 staining which lacked either STAT3 or
phospho-STAT3 expression, indicating the presence of both
STAT3-dependent and STAT3-independent pathways for bcl2
gene induction.
Our finding that suppressed serum levels of TSH were
significantly associated with a lack of STAT3 expression
was not fully unexpected, since thyrotropin is known to in-
duce transcriptional activation of STAT3 [28]. Previous stud-
ies have shown that upon stimulation of rat thyroid cells with
TSH, STAT3, and not STAT1, is rapidly tyrosine phosphory-
lated, pointing to the role of STAT3 as a transcriptional acti-
vator for TSH-induced proliferative responses [29–31]. Our
observation of a colocalization of STAT3 and Bcl-2 in a
number of hyperplastic and oxyphilic thyroid follicles may
indicate that STAT3 confers protection against cell death via
transcriptional activation of antiapoptotic Bcl-2. Of course,
from our small sample size comprising patients with chronic,
long-lasting thyroiditis, we cannot exclude the possibility that
thyroidal expression of STAT3 may be more prominent in
earlier stages of the disease.
A central finding in our study cohort of patients with
lymphocytic thyroiditis was that an increase in stromal
fibrosis was associated with reduced levels of STAT3 acti-
vation. Furthermore, we found that STAT3 expression was
restricted to epithelial cells and was completely absent in
Fig. 4 Colocalization of Bcl-2 (a), phospho-STAT3 (b), and STAT5
(b) in oncocytes as determined by staining serial sections with the
corresponding antibodies. A cluster of three thyroid follicles (TFs) is
marked with arrows. Note the absence of phospho-STAT3 expression
in lymphocytes and the differential distribution of STAT5 and Bcl-2 in
the constituting cells of the adjacent lymph node (LN)
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infiltrating T cells. These findings were unexpected, since
STAT3 has been implicated in the development of autoim-
mune reactions. Interleukin-23 (IL-23) has been shown to
stimulate naive CD4+ T cells via STAT3 activation to dif-
ferentiate into IL-17-producing Th17 cells [32]. In turn,
proinflammatory IL-17 induces the release of IL-6, which
also upregulates prosurvival and proangiogenic genes
through activation of STAT3 [32]. Our immunohistochemi-
cal results suggest that intrathyroidal proliferation of mem-
ory CD4+ T cells is not the key mechanism for STAT3
activation in lymphocytic thyroiditis and, moreover, that
this transcription factor counteracts the autoimmune attack
by reconstituting the inflamed organ via its direct effects on
Bcl2-expressing thyrocytes. In this scenario, the glycopro-
tein 130–STAT3 pathway, known to be essential for Th17
development, may promote the growth and proliferation of
regenerating thyroid follicles, thereby providing protection
against an autoimmune destruction of the thyroid gland.
Further experiments will have to elucidate the complex,
and probably cell-type-specific antagonistic actions of the
STAT3 transcription factor in the pathogenesis of this auto-
immune disease.
The presence of STAT1 in all of our patients and its
antagonistic counterpart STAT3 in half of the study popula-
tion indicates the concurrent presence of both degenerative
and regenerative processes during follicle remodeling. Cel-
lular distribution of STAT5 was clearly distinguishable from
the other two STAT proteins described above, since it was
detected in numerous lymphocytes scattered throughout the
intrathyroidal infiltrates and also in hyperplastic epithelium
lining-affected thyroid follicles. STAT5 expression in infil-
trating lymphocytes was expected because it is well known
that activation of STAT5 in response to IL-7 receptor sig-
naling facilitates cell survival in early B cell development
and controls immunoglobulin gene rearrangements by sup-
pressing premature Igk recombination in pro-B cells [14].
Surprisingly, however, activated STAT5 molecules were
additionally found in numerous spheroidal thyroid follicles
of reduced size that were tightly filled with colloid. This
epithelial STAT5 expression in most, but not all, patients
with lymphocytic thyroiditis resembles the histological fea-
tures of the lobuloalveolar STAT5 distribution which have
been reported for the normal development of the mammary
gland during lactogenesis [13, 33]. Given the remarkable
regeneration capacity of the human thyroid gland [2], we
hypothesize that STAT5 is expressed mainly in regenerating
thyroid follicles where it functions to restore the normal
follicular structure of the organ. Further experiments will
have to show whether indeed the course of murine experi-
mental autoimmune thyroiditis is aggravated in transgenic
mice lacking STAT5a/b expression in the thyroid gland.
Altogether, our immunohistochemical analysis in patients
with lymphocytic thyroiditis demonstrated differential and
cell-type-specific expression patterns for distinct members
of the STAT protein family. Besides being expressed in a
portion of infiltrating lymphocytes and germinal macro-
phages, tyrosine-phosphorylated STAT1 was associated
with the transformation of normal follicular thyrocytes to
typical oncocytes. In contrast, STAT3 expression was con-
fined to epithelial cells and displayed clear colocalization
with Bcl-2, suggesting that STAT3 executes protective func-
tions in the tissue remodeling of the inflamed thyroid gland
by upregulating antiapoptotic Bcl-2. STAT5 immunoreac-
tivity was detected in both infiltrating cells of hematopoietic
origin and hyperplastic follicular epithelium, demonstrating
that STAT5 participates both in lymphocytopoiesis and pos-
sibly also in the buildup of newly formed follicle structures.
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